The future is here: Genome Sequencing as the first line prenatal diagnostic testing

Genome sequencing (GS) has emerged as a promising alternative to existing prenatal diagnostic methods. GS offers a single, high-resolution approach capable of simultaneously detecting a broad spectrum of genetic alterations below the detection threshold of CMA, impacting medical management in pregnancy, delivery, and neonatal care. In this webinar, we will assess the upcoming implementation of genomes sequencing as the first-tier prenatal diagnostic test for all patients and consider the implications for non-invasive exome/genome sequencing. We will additionally consider the value of community and data sharing to drive this field forward. 

Presented by: NSGC Prenatal SIG 

Jessica L. Giordano, MS, CGC 

Date: February 4, 2026 

Learning Objectives: 

1. Examine the value of genome sequencing in prenatal diagnosis as a single-tier, comprehensive test for all patients
2. Assess benefits and limitations of different sequencing consenting and reporting strategies
3. Explore the future state of non-invasive exome/genome sequencing
4. Discuss the value of community and data sharing to move the field of prenatal diagnosis forward 

Continuing Education Unit Approval: 

The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for The future is here: Genome Sequencing as the first line prenatal diagnostic testing. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. 

Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation